Last month, drug company Genentech reported on the first clinical trials of the drug crenezumab, a drug targeting amyloid proteins that form sticky plaques in the brains of Alzheimer’s disease patients. The drug had been particularly effective in...
@blackfire@lemmy.ml
link
fedilink
310 hilabete

Damn thats insane. I remember hearing about the study and it being a big step in medical field. How did nobody peer reviewing it look at the images and compare them. Shows a broken system

Create a post

Subscribe to see new publications and popular science coverage of current research on your homepage


  • 0 users online
  • 7 users / day
  • 19 users / week
  • 34 users / month
  • 107 users / 6 months
  • 8 subscribers
  • 1.04K Posts
  • 1.11K Comments
  • Modlog